Equities

Biora Therapeutics Inc

Biora Therapeutics Inc

Actions
  • Price (EUR)0.478
  • Today's Change-4.30 / -90.00%
  • Shares traded--
  • 1 Year change-96.29%
  • Beta--
Data delayed at least 15 minutes, as of Oct 17 2024 18:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments153088
Total Receivables, Net0.830.830.65
Total Inventory------
Prepaid expenses2.443.636.12
Other current assets, total0.593.173.60
Total current assets193899
Property, plant & equipment, net2.773.143.67
Goodwill, net6.076.076.07
Intangibles, net------
Long term investments3.006.000
Note receivable - long term------
Other long term assets0.300.200.33
Total assets3154109
LIABILITIES
Accounts payable2.843.618.71
Accrued expenses151431
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.9800.01
Other current liabilities, total445.6422
Total current liabilities632362
Total long term debt44128126
Total debt46128126
Deferred income tax------
Minority interest------
Other liabilities, total264.705.81
Total liabilities133156194
SHAREHOLDERS EQUITY
Common stock0.030.010.01
Additional paid-in capital869744723
Retained earnings (accumulated deficit)(951)(827)(789)
Treasury stock - common(19)(19)(19)
Unrealized gain (loss)------
Other equity, total------
Total equity(101)(102)(85)
Total liabilities & shareholders' equity3154109
Total common shares outstanding2.780.890.73
Treasury shares - common primary issue0.070.020.02
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.